These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1372760)

  • 1. Prognostic factors in metastatic disease.
    Droz JP; Kramar A; Rey A
    Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
    [No Abstract]   [Full Text] [Related]  

  • 2. Testicular cancer. Clinical practice guidelines in oncology.
    Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
    von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
    Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for stage I nonseminoma.
    Feldman DR
    J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
    Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
    Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
    Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
    J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
    Sheinfeld J
    Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
    [No Abstract]   [Full Text] [Related]  

  • 10. Germ cell tumours of testis: prognostic factors and results.
    Nikzas D; Champion AE; Fox M
    Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
    Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
    Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
    Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 15. Testicular cancer: role of biological tumor markers.
    Pearson JC; Spaulding JT; Friedman MA
    Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
    [No Abstract]   [Full Text] [Related]  

  • 16. Testicular cancer: risk stratification in adolescents with nonseminoma.
    Looijenga LH
    Nat Rev Urol; 2014 Jul; 11(7):367-8. PubMed ID: 24960597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK
    Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
    Wood DP; Herr HW; Motzer RJ; Reuter V; Sogani PC; Morse MJ; Bosl GJ
    Cancer; 1992 Nov; 70(9):2354-7. PubMed ID: 1382832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of management of pediatric testicular germ cell tumors.
    Ye YL; Sun XZ; Zheng FF; Bian J; Huang YP; Zhang XQ; Li ZX; Nie Y; Qin ZK; Dai YP
    Urology; 2012 Apr; 79(4):892-7. PubMed ID: 22305424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.